Candor Ivf Center Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.17 Cr
- Company Age 1 Year 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.28 M
About Candor Ivf Center
Candor Ivf Center Private Limited (CICPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 2023 (One year and five months 8 days old ). Its registered office is in Surat, Gujarat, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.17 Cr.
The company currently has active open charges totaling ₹3.28 M.
Jaydev Dhameliya, Viral Dhameliya, and Juhi Dhameliya serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U86100GJ2023PTC144506
-
Company No.
144506
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Sep 2023
-
Date of AGM
19 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Who are the key members and board of directors at Candor Ivf Center?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Juhi Dhameliya
|
Director | 06-Sep-2023 | Current |
|
Jaydev Dhameliya
|
Director | 06-Sep-2023 | Current |
| Viral Dhameliya | Director | 14-Jun-2024 | Current |
Financial Performance of Candor Ivf Center.
Enhance accessibility to Candor Ivf Center's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Candor Ivf Center?
Unlock access to Candor Ivf Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Medisun Lifescience Private LimitedJuhi Dhameliya is a mutual person
-
Candor Ivf Center And Research Institute Private LimitedJaydev Dhameliya and Juhi Dhameliya are mutual person
Charges (Loans)
₹0.33 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2024 | Others | ₹3.28 M | Open |
How Many Employees Work at Candor Ivf Center?
Unlock and access historical data on people associated with Candor Ivf Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Candor Ivf Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Candor Ivf Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.